667, L.P.
- SEC CIK
- 0001551139
In the past year, 2 open-market purchase filings worth $232.5M and 1 sale filing worth $262.0K.
Current role at each company
- ONC BeOne Medicines Ltd.Directoras of Sep 16, 2026
- REPL Replimune Group, Inc.Director, 10% Owneras of Aug 11, 2026
- KOD Kodiak Sciences Inc.Director, 10% Owneras of Jul 2, 2026
- INCY Incyte CorpDirector, 10% Owneras of Jul 2, 2026
- VTVT vTv Therapeutics Inc.Directoras of Jun 29, 2026
Show 14 more companies
- KYMR Kymera Therapeutics, Inc.Director, 10% Owneras of Jun 25, 2026
- MDGL Madrigal Pharmaceuticals, Inc.Directoras of Jun 18, 2026
- PRLD Prelude Therapeutics IncDirector, 10% Owneras of Jun 10, 2026
- DNLI Denali Therapeutics Inc.Directoras of Jun 5, 2026
- ACAD Acadia Pharmaceuticals IncDirector, 10% Owneras of Jun 2, 2026
- KNSA Kiniksa Pharmaceuticals International, plcDirectoras of Jun 2, 2026
- TCRX TScan Therapeutics, Inc.Directoras of May 22, 2026
- DBVT DBV Technologies S.A.Directoras of Jan 14, 2026
- BCYC Bicycle Therapeutics PLCDirector, 10% Owneras of Jan 6, 2026
- IGMS IGM Biosciences, Inc.Other: Former 10% owner and directoras of Aug 18, 2025
- IMCR Immunocore Holdings plcDirectoras of May 19, 2025
- NGNE Neurogene Inc.Director, Other: Former 10% Owneras of Dec 20, 2023
- SGEN Seagen Inc.Director, Other: Former 10% Owneras of Dec 18, 2023
- TLIS Talis Biomedical CorpDirector, 10% Owneras of Jun 13, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $232.5M
- 2 filings
- Sold
- $262.0K
- 1 filing
- Net
- +$232.2M
- Bought minus sold
- Companies
- 3
- With open-market trades
Trades
Every Form 4 that lists 667, L.P. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
REPL Replimune Group, Inc.
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 11, 2026 (view filing)5:46 PM ET | Aug 11 | Same day | Baker Julian and 5 othersDirector, 10% Owner | PPurchase | +2.74M | $12.06 | +$33.0M | –2.61M after | Derivative2 lots |
ONC BeOne Medicines Ltd.
Director4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 27, 2026 (view filing)4:54 PM ET | May 22 | 5 days | Baker Julian and 5 othersDirector | SSale | −11.0K | $23.82 | −$262.0K | −7.2%142.6K after | 4 lots |
| Feb 28, 2025 (view filing)9:28 PM ET | Feb 28 | Same day | Baker Julian and 5 othersDirector | SSaleAmerican Depositary Shares | −732.8K | $260.00 | −$190.5M | −8.3%8.07M after | 2 lots |
| Dec 10, 2024 (view filing)9:25 PM ET | Dec 9 | 1 day | Baker Julian and 5 othersDirector | SSaleAmerican Depositary Shares | −1.04M | $187.27 | −$194.2M | −10.6%8.74M after | 4 lots |
| Nov 14, 2023 (view filing)5:54 PM ET | Nov 14 | Same day | Baker Julian and 5 othersDirector, 10% Owner | SSaleAmerican Depositary Shares | −1.10M | $180.50 | −$198.6M | −10.2%9.69M after | 2 lots |
PRLD Prelude Therapeutics Inc
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 22, 2026 (view filing)4:15 PM ET | Apr 21 | 1 day | Baker Julian and 5 othersDirector, 10% Owner | PPurchase | +2.25M | $4.44 | +$10.0M | –20.1M after | Derivative2 lots |
KOD Kodiak Sciences Inc.
Director, 10% Owner12 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2025 (view filing)4:06 PM ET | Dec 18 | 1 day | Baker Julian and 5 othersDirector, 10% Owner | PPurchase | +2.61M | $23.00 | +$60.0M | +16.6%18.4M after | 2 lots |
| Jun 6, 2022 (view filing)5:08 PM ET | Jun 2-6 | 4 days | Baker Julian and 5 othersDirector, 10% Owner | PPurchase | +572.3K | $7.77 | +$4.45M | +3.7%16.0M after | 12 lots |
| May 27, 2022 (view filing)4:44 PM ET | May 25-27 | 2 days | Baker Julian and 5 othersDirector, 10% Owner | PPurchase | +350.4K | $6.75 | +$2.36M | +2.3%15.5M after | 16 lots |
| May 18, 2022 (view filing)5:30 PM ET | May 16-18 | 2 days | Baker Julian and 5 othersDirector, 10% Owner | PPurchase | +456.7K | $5.91 | +$2.70M | +3.1%15.1M after | 14 lots |
| Feb 17, 2022 (view filing)5:33 PM ET | Feb 15-17 | 2 days | Baker Julian and 5 othersDirector, 10% Owner | PPurchase | +401.0K | $54.45 | +$21.8M | +2.8%14.7M after | 10 lots |
| Jan 31, 2022 (view filing)5:06 PM ET | Jan 27-31 | 4 days | Baker Julian and 5 othersDirector, 10% Owner | PPurchase | +347.7K | $52.02 | +$18.1M | +2.5%14.4M after | 12 lots |
| Jan 25, 2022 (view filing)5:40 PM ET | Jan 21-25 | 4 days | Baker Julian and 5 othersDirector, 10% Owner | PPurchase | +501.1K | $57.49 | +$28.8M | +3.7%14.0M after | 10 lots |
| Oct 1, 2021 (view filing)4:58 PM ET | Sep 30 | 1 day | Baker Julian and 5 othersDirector, 10% Owner | PPurchase | +86.9K | $95.83 | +$8.33M | +0.6%13.5M after | |
| Sep 17, 2021 (view filing)6:05 PM ET | Sep 15-16 | 2 days | Baker Julian and 5 othersDirector, 10% Owner | PPurchase | +31.8K | $94.39 | +$3.01M | +0.2%13.3M after | 3 lots |
| Sep 9, 2021 (view filing)6:43 PM ET | Sep 7 | 2 days | Baker Julian and 5 othersDirector, 10% Owner | PPurchase | +57.5K | $93.31 | +$5.37M | +0.4%13.3M after | 2 lots |
DNLI Denali Therapeutics Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 15, 2025 (view filing)4:33 PM ET | Dec 11 | 4 days | Baker Julian and 5 othersDirector | PPurchase | +2.29M | $17.49 | +$40.0M | –26.0M after | Derivative2 lots |
KYMR Kymera Therapeutics, Inc.
Director, 10% Owner5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 11, 2025 (view filing)4:19 PM ET | Dec 11 | Same day | Baker Julian and 5 othersDirector, 10% Owner | PPurchase | +2.01M | $86.00 | +$172.5M | +33.7%7.96M after | 2 lots |
| Jun 30, 2025 (view filing)8:15 PM ET | Jun 30 | Same day | Baker Julian and 5 othersDirector | PPurchase | +655.5K | $44.00 | +$28.8M | +12.0%6.12M after | 2 lots |
| Jun 30, 2025 (view filing)8:15 PM ET | Jun 30 | Same day | Baker Julian and 5 othersDirector | PPurchase | +655.5K | $44.00 | +$28.8M | –10.2M after | Derivative2 lots |
| Aug 22, 2024 (view filing)4:03 PM ET | Aug 20 | 2 days | Baker Julian and 5 othersDirector | PPurchase | +1 | $46.41 | +$46.41 | 0.0%5.52M after | |
| Aug 22, 2024 (view filing)4:03 PM ET | Aug 21 | 1 day | Baker Julian and 5 othersDirector | PPurchase | +2.59M | $40.75 | +$105.7M | –9.63M after | Derivative2 lots |
MDGL Madrigal Pharmaceuticals, Inc.
Director9 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 20, 2025 (view filing)6:12 PM ET | Aug 18-20 | 2 days | Baker Julian and 5 othersDirector | PPurchase | +97.1K | $380.58 | +$36.9M | +5.2%1.95M after | 26 lots |
| Aug 20, 2025 (view filing)6:09 PM ET | Aug 18 | 2 days | Baker Julian and 5 othersDirector | PPurchase | +68.6K | $364.04 | +$25.0M | +3.8%1.86M after | 28 lots |
| Dec 14, 2023 (view filing)6:10 PM ET | Dec 13-14 | 1 day | Baker Julian and 5 othersDirector | PPurchase | +101.8K | $221.20 | +$22.5M | +6.0%1.79M after | 24 lots |
| Dec 14, 2023 (view filing)6:09 PM ET | Dec 12 | 2 days | Baker Julian and 5 othersDirector | PPurchase | +34.6K | $218.31 | +$7.55M | +2.1%1.70M after | 30 lots |
| Nov 21, 2023 (view filing)6:15 PM ET | Nov 21 | Same day | Baker Julian and 5 othersDirector | PPurchase | +64.3K | $188.47 | +$12.1M | +4.0%1.67M after | 20 lots |
| Nov 21, 2023 (view filing)6:14 PM ET | Nov 17-20 | 4 days | Baker Julian and 5 othersDirector | PPurchase | +67.1K | $178.11 | +$11.9M | +4.4%1.61M after | 30 lots |
| Nov 15, 2023 (view filing)5:13 PM ET | Nov 14-15 | 1 day | Baker Julian and 5 othersDirector | PPurchase | +49.4K | $158.13 | +$7.81M | +3.3%1.55M after | 4 lots |
| Nov 15, 2023 (view filing)5:12 PM ET | Nov 13-14 | 2 days | Baker Julian and 5 othersDirector | PPurchase | +107.5K | $146.99 | +$15.8M | +7.7%1.50M after | 30 lots |
| Oct 5, 2023 (view filing)4:27 PM ET | Oct 3 | 2 days | Baker Julian and 5 othersDirector | PPurchase | +1.65M | $151.69 | +$250.0M | –1.52M after | Derivative2 lots |
IMCR Immunocore Holdings plc
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 19, 2025 (view filing)6:40 PM ET | Mar 17 | 2 days | Baker Julian and 5 othersDirector | PPurchaseAmerican Depositary Shares | +807.3K | $29.72 | +$24.0M | +60.4%2.14M after | 4 lots |
| Mar 19, 2025 (view filing)6:40 PM ET | Mar 17 | 2 days | Baker Julian and 5 othersDirector | SSaleAmerican Depositary Shares | −1.58M | – | – | –0 after | Derivative2 lotsPrice outlier |
BCYC Bicycle Therapeutics PLC
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 17, 2024 (view filing)6:03 PM ET | Dec 13-16 | 4 days | Baker Julian and 5 othersDirector, 10% Owner | PPurchaseAmerican Depositary Shares | +1.49M | $14.29 | +$21.2M | +17.5%10.0M after | 10 lots |
TCRX TScan Therapeutics, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 23, 2024 (view filing)4:17 PM ET | Apr 19 | 4 days | Baker Julian and 5 othersDirector | PPurchase | +9.68M | $7.13 | +$69.0M | –43.2M after | Derivative2 lots |
| May 12, 2022 (view filing)4:41 PM ET | May 10-11 | 2 days | Baker Julian and 5 othersDirector, 10% Owner | PPurchase | +1.36M | $1.88 | +$2.56M | +116.3%2.53M after | 8 lots |
| Jul 22, 2021 (view filing)4:06 PM ET | Jul 20 | 2 days | Baker Julian and 5 othersDirector | PPurchase | +1.43M | $15.00 | +$21.4M | New position1.32M after | 2 lots |
IGMS IGM Biosciences, Inc.
Other: Former 10% owner and director4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 28, 2024 (view filing)7:04 PM ET | Mar 26-28 | 2 days | Baker Julian and 5 othersDirector, 10% Owner | PPurchase | +395.3K | $8.67 | +$3.43M | +11.8%3.75M after | 8 lots |
| Dec 15, 2023 (view filing)5:32 PM ET | Dec 13-15 | 2 days | Baker Julian and 5 othersDirector, 10% Owner | PPurchase | +532.7K | $6.44 | +$3.43M | +18.6%3.39M after | 12 lots |
| Jun 28, 2023 (view filing)5:00 PM ET | Jun 26 | 2 days | Baker Julian and 5 othersDirector | PPurchase | +5.63M | $8.00 | +$45.0M | –9.89M after | Derivative2 lots |
| Apr 5, 2022 (view filing)4:32 PM ET | Apr 1 | 4 days | Baker Julian and 5 othersDirector, 10% Owner | PPurchase | +2.83M | $23.00 | +$65.0M | –4.67M after | Derivative2 lots |
NGNE Neurogene Inc.
Director, Other: Former 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2023 (view filing)5:08 PM ET | Aug 15-17 | 2 days | Baker Julian and 5 othersDirector, 10% Owner | PPurchase | +2.29M | $0.6404 | +$1.46M | +68.7%5.61M after | 12 lots |
ACAD Acadia Pharmaceuticals Inc
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 24, 2023 (view filing)5:09 PM ET | May 22-24 | 2 days | Baker Julian and 5 othersDirector, 10% Owner | PPurchase | +896.5K | $25.33 | +$22.7M | +2.3%39.3M after | 14 lots |
INCY Incyte Corp
Director, 10% Owner4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 10, 2022 (view filing)6:02 PM ET | Mar 8-10 | 2 days | Baker Julian and 5 othersDirector, 10% Owner | PPurchase | +389.1K | $72.24 | +$28.1M | +1.2%33.4M after | 10 lots |
| Feb 22, 2022 (view filing)5:45 PM ET | Feb 17-22 | 5 days | Baker Julian and 5 othersDirector, 10% Owner | PPurchase | +525.8K | $67.96 | +$35.7M | +1.6%33.0M after | 8 lots |
| Feb 14, 2022 (view filing)5:23 PM ET | Feb 10-14 | 4 days | Baker Julian and 5 othersDirector, 10% Owner | PPurchase | +1.60M | $66.91 | +$107.0M | +5.2%32.5M after | 7 lots |
| Dec 17, 2021 (view filing)6:30 PM ET | Dec 15-17 | 2 days | Baker Julian and 5 othersDirector, 10% Owner | PPurchase | +1.60M | $72.43 | +$115.6M | +5.4%30.9M after | 10 lots |
SGEN Seagen Inc.
Director, Other: Former 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 2, 2021 (view filing)6:51 PM ET | Nov 30-Dec 1 | 2 days | Baker Julian and 5 othersDirector, 10% Owner | SSale | −394.9K | $160.54 | −$63.4M | −0.9%42.9M after | 20 lots |
TLIS Talis Biomedical Corp
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 19, 2021 (view filing)4:09 PM ET | Nov 18 | 1 day | Baker Julian and 5 othersDirector, 10% Owner | PPurchase | +50.0K | $4.37 | +$218.3K | +0.7%7.05M after |